Cardiovascular Diseases

Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.

Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.

<p>Dr Kevin Maki, from Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.</p>

<p>Dr Seth Baum, President of the American Society for Preventive Cardiology, discusses his recent paper on PCSK9 inhibitors.</p>

<p>In this podcast, Dr. Charles Hennekens from Florida Atlantic University discusses his recent commentary on smoking cessation using varenicline.</p>

<p>In this podcast, Dr. Charles Hennekens from Florida Atlantic University discusses his recent commentary on smoking cessation using varenicline.</p>

Dr William Boden from the VA New England Healthcare System discusses the key takeaways from his session about coronary stenting at the American Society for Preventive Cardiology's 2018 Congress on CVD...

<p>Stefanos Haddad, lead author of the July 2017 Photo Quiz, talks about his case report.</p>

<p>Stefanos Haddad, lead author of the July 2017 Photo Quiz, talks about his case report.</p>

<p>Dr. Robert Rosenson from the Mount Sinai School of Medicine discusses his latest research about high-intensity statin use and its benefits for patients with cardiovascular disease.</p>